Financial Times: An effective vaccine against malaria may at last be in sight
Joe Cohen, adviser to the malaria vaccine project at GlaxoSmithKline

“…While huge progress has been made during the past decade, thanks to bed nets, better treatments and diagnostic tools, [malaria] still claims hundreds of thousands of lives each year — mostly young African children. The need for new approaches is as relevant now as it was then. … We will always need to look for better approaches to stay ahead and, I hope, to make malaria history” (4/25).